Table 3 Multivariate analysis of prognostic factors in patients with metastatic NPC
Characteristic | Model 1 | Model 2 | ||
|---|---|---|---|---|
| Â | HR (95Â % CI) | P value | HR (95Â % CI) | P value |
N stage (N2-3 vs. N0-1) | 1.42(1.18, 1.72) | <0.001 | 1.39(1.15,1.68) | 0.001 |
Number of metastatic lesions (≥2 vs. 1) | 1.73(1.29, 2.32) | <0.001 | 1.87(1.40,2.52) | <0.001 |
Liver metastasis (present vs. absent) | 1.38(1.14, 1.67) | 0.001 | 1.29(1.06,1.57) | 0.010 |
Lymphocyte count (≥1.390 × 109/L vs. <1.390 × 109/L) | NA | NA | 0.77(0.64,0.93) | 0.007 |
Monocyte count (≥0.665 × 109/L vs. <0.665 × 109/L) | NA | NA | 1.98(1.63,2.41) | <0.001 |
LMR (≥2.475 vs. <2.475) | 0.50(0.41, 0.60) | <0.001 | NA | NA |